Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2017Journal
JACC: Heart FailurePublisher
Elsevier Inc.Type
Article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018678907&doi=10.1016%2fj.jchf.2017.03.005&partnerID=40&md5=12a13825d5126d0f313e5e2deb5e6f88; http://hdl.handle.net/10713/10920ae974a485f413a2113503eed53cd6c53
10.1016/j.jchf.2017.03.005
Scopus Count
Collections
Related articles
- Endothelin receptor blockade in congestive heart failure.
- Authors: Cheng TO
- Issue date: 2001 Oct 30
- New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
- Authors: Suresh DP, Lamba S, Abraham WT
- Issue date: 2000 Dec
- Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists.
- Authors: Nishimura M, Tokoro T, Yamazaki S, Hashimoto T, Kobayashi H, Ono T
- Issue date: 2017 Dec
- Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders.
- Authors: Goddard J, Webb DJ
- Issue date: 1999 Jul
- Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
- Authors: Langleben D
- Issue date: 2007 Mar